Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Deficits in plasma oestradiol measurement in studies and management of breast cancer.

    Dowsett M, Folkerd E.

    Breast Cancer Res. 2005;7(1):1-4. Epub 2004 Oct 28. Review.

    PMID:
    15642174
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Pre-operative oestradiol levels - relation to survival in breast cancer.

    Holmberg L, Nordén T, Lindgren A, Wide L, Degerman M, Adami HO.

    Eur J Surg Oncol. 2001 Mar;27(2):152-6.

    PMID:
    11289750
    [PubMed - indexed for MEDLINE]
    3.

    Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

    J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

    PMID:
    15840882
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.

    Geisler J, Haynes B, Ekse D, Dowsett M, Lønning PE.

    J Steroid Biochem Mol Biol. 2007 Apr;104(1-2):27-34. Epub 2007 Mar 9.

    PMID:
    17350249
    [PubMed - indexed for MEDLINE]
    5.

    Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

    J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

    PMID:
    16418513
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Limitations of direct estradiol and testosterone immunoassay kits.

    Stanczyk FZ, Cho MM, Endres DB, Morrison JL, Patel S, Paulson RJ.

    Steroids. 2003 Dec;68(14):1173-8.

    PMID:
    14643879
    [PubMed - indexed for MEDLINE]
    7.

    Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.

    Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A.

    Breast Cancer Res Treat. 2008 Mar;108(1):57-67. Epub 2007 Apr 28.

    PMID:
    17468953
    [PubMed - indexed for MEDLINE]
    8.

    Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.

    Hogervorst E, Williams J, Combrinck M, David Smith A.

    Eur J Endocrinol. 2003 Jan;148(1):67-72.

    PMID:
    12534359
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

    Tamimi RM, Byrne C, Colditz GA, Hankinson SE.

    J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.

    PMID:
    17652278
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

    J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

    PMID:
    17018787
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.

    Geisler J, Ekse D, Helle H, Duong NK, Lønning PE.

    J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):90-5. Epub 2007 Dec 15.

    PMID:
    18242079
    [PubMed - indexed for MEDLINE]
    12.

    Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.

    Ju YH, Allred KF, Allred CD, Helferich WG.

    Carcinogenesis. 2006 Jun;27(6):1292-9. Epub 2006 Mar 14.

    PMID:
    16537557
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.

    Hernández L, Nuñez-Villarl MJ, Martínez-Arribas F, Pollán M, Schneider J.

    Anticancer Res. 2005 Jan-Feb;25(1B):451-4.

    PMID:
    15816610
    [PubMed - indexed for MEDLINE]
    14.

    Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.

    Eliassen AH, Tworoger SS, Hankinson SE.

    Int J Cancer. 2007 Apr 1;120(7):1536-41.

    PMID:
    17211859
    [PubMed - indexed for MEDLINE]
    15.

    Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.

    Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, Berrino F, Muti P.

    Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):169-76.

    PMID:
    19124495
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Biomarkers associated with breast cancer are associated with obesity.

    Sauter ER, Scott S, Hewett J, Kliethermes B, Ruhlen RL, Basarakodu K, de la Torre R.

    Cancer Detect Prev. 2008;32(2):149-55. Epub 2008 Jul 17.

    PMID:
    18639389
    [PubMed - indexed for MEDLINE]
    17.

    The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer.

    Folkerd EJ, Martin LA, Kendall A, Dowsett M.

    J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):250-5. Epub 2006 Oct 17. Review.

    PMID:
    17049846
    [PubMed - indexed for MEDLINE]
    18.

    Prospective breast cancer risk prediction model for women undergoing screening mammography.

    Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

    J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

    PMID:
    16954473
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.

    Endocr Relat Cancer. 2005 Dec;12(4):1071-82.

    PMID:
    16322344
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies.

    Stanczyk FZ, Jurow J, Hsing AW.

    Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):903-6. Epub 2010 Mar 23.

    PMID:
    20332268
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk